共查询到20条相似文献,搜索用时 15 毫秒
1.
2.
《BMJ (Clinical research ed.)》1969,1(5640):335-342
This report describes the design and results of a controlled trial of anticoagulant drugs in the treatment of patients admitted to hospital suffering from acute myocardial infarction. A total of 1,427 patients were allocated at random to therapy with high-dosage or low-dosage anticoagulants. The high-dosage regimen was 36 hours of heparin administration and phenindione in doses to maintain the thrombotest level between 10 and 20%. The mean phenindione dosage was 72 mg./day. The low-dosage regimen consisted of 1-mg. tablets of phenindione. Therapy was continued for 28 days.There was no significant reduction in the mortality in the high-dosage group. Among the 712 patients allocated to high dosage 115 (16·2%) died before the 29th day of the trial. Of the 715 patients allocated to low dosage 129 (18%) died. This difference between these mortality rates could have occurred by chance.There was a significant reduction in the frequency of clinically evident thromboembolic complications (systemic artery occlusion, leg vein thrombosis, and pulmonary embolism) among patients in the high-dosage group. This did not, however, materially affect the difference in mortality from all causes. 相似文献
3.
Chr. F. Borchgrevink Chr. Bjerkelund A. M. Abrahamsen G. Bay P. Borgen B. Grande I. Helle H. Kj?rstad A. M. Petersen T. R?rvik R. Thorsen A. ?degaard 《BMJ (Clinical research ed.)》1968,3(5618):571-574
A multicentre trial from five medical departments in Oslo has been carried out to determine the value in women patients of one year''s long-term anticoagulant therapy. Follow-up long-term laboratory control and anticoagulant dosage were performed at one centre (the Rikshospitalet). One hundred and fifty-nine patients were assigned randomly into two similar well-matched groups (control and treatment). Dosage was controlled by Thrombotest, aiming at 10–20% levels, and 50% of the tests were less than 14%. Compared with the control group, the treatment group showed a significant reduction in mortality and in reinfarction rate. No serious bleeding complications occurred. It is concluded that women benefit as much as men from long-term anticoagulant therapy. 相似文献
4.
5.
6.
7.
8.
G. R. Fearnley 《BMJ (Clinical research ed.)》1959,1(5129):1115-1116
9.
10.
11.
12.
13.
《BMJ (Clinical research ed.)》1950,2(4686):991-992
14.
15.
16.
17.
《The Western journal of medicine》1962,96(1):72.1-1,80
18.
19.
20.